FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065526578> ?p ?o ?g. }

• W2065526578 endingPage "1084" @default.
• W2065526578 startingPage "1076" @default.
• W2065526578 abstract "The definitive effect of induction chemotherapy (IC) on locally advanced head and neck squamous cell carcinoma (HNSCC) remains uncertain and although randomized controlled trials are supposed to provide high levels evidence for clinical guidelines, the data thus far has been conflicted. In an effort to elucidate the potential benefit of IC, a meta-analysis of randomized controlled trials (1965-2011) was performed investigating the impact of IC on survival, locoregional control, distant metastasis, and toxicity in HNSCC. Kaplan-Meier curves were read by a digitizing software-Engauge Digitizer. Data combination was performed using the software-RevMan and trial level log hazard ratio (HR) and variance were pooled and presented. Among the 40 eligible trials, 28 trials encompassing 4189 patients receiving locoregional treatment with or without IC were included in the analysis. The cumulative benefit of IC on overall survival and distant metastasis was 6% (HR = 0.94, 95%CI = 0.87-1.01, P = 0.11) and 7% (95%CI = 0-13%, P = 0.05) respectively while for locoregional control a benefit was not observed as seen by the -2% (95%CI = -11% to 8%, P = 0.73) improved control rate. In a subsite analysis specifically for laryngeal preservation, IC did not significantly improve survival (P = 0.47). There was a significant benefit from the cisplatin and 5-fluorouracil (PF) protocols with an increase in overall survival of 13% (HR = 0.87, 95%CI = 0.78-0.97, P = 0.01), and a reduction in the 5-year distant metastasis rate of 11% (95%CI = 0-21%, P = 0.04). The occurrence of grade 3/4 mucositis, leukopenia and emesis was significantly lower in patients receiving IC compared to patients receiving concomitant chemoradiotherapy. In conclusion, there is not a significant benefit of the pooled IC regimens in HNSCC on survival or locoregional control. In contrast, IC does show significant benefit in the reduction of distant metastasis. When protocols using a PF regimen are analyzed independently, a significant improvement in survival and rate of distant metastases is observed while there is not a benefit in locoregional control. The routine use of IC is still debatable. IC could be applied on larynx preservation strategy." @default.
• W2065526578 created "2016-06-24" @default.
• W2065526578 creator A5041471791 @default.
• W2065526578 creator A5060002817 @default.
• W2065526578 creator A5068859775 @default.
• W2065526578 creator A5072824146 @default.
• W2065526578 creator A5080374144 @default.
• W2065526578 creator A5082631468 @default.
• W2065526578 creator A5085366844 @default.
• W2065526578 date "2012-11-01" @default.
• W2065526578 modified "2023-10-14" @default.
• W2065526578 title "Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or locoregional control: A meta-analysis" @default.
• W2065526578 cites W1904941427 @default.
• W2065526578 cites W1912423223 @default.
• W2065526578 cites W1968737726 @default.
• W2065526578 cites W1975828423 @default.
• W2065526578 cites W1983970003 @default.
• W2065526578 cites W1992815288 @default.
• W2065526578 cites W1992977889 @default.
• W2065526578 cites W1998289040 @default.
• W2065526578 cites W2000219306 @default.
• W2065526578 cites W2003278673 @default.
• W2065526578 cites W2010402293 @default.
• W2065526578 cites W2010410598 @default.
• W2065526578 cites W2019948754 @default.
• W2065526578 cites W2020830322 @default.
• W2065526578 cites W2022395184 @default.
• W2065526578 cites W2022445051 @default.
• W2065526578 cites W2035632263 @default.
• W2065526578 cites W2046255941 @default.
• W2065526578 cites W2046830562 @default.
• W2065526578 cites W2050188791 @default.
• W2065526578 cites W2051536825 @default.
• W2065526578 cites W2057544385 @default.
• W2065526578 cites W2059275582 @default.
• W2065526578 cites W2065616603 @default.
• W2065526578 cites W2066598663 @default.
• W2065526578 cites W2072680387 @default.
• W2065526578 cites W2072694609 @default.
• W2065526578 cites W2072747210 @default.
• W2065526578 cites W2073730951 @default.
• W2065526578 cites W2075642745 @default.
• W2065526578 cites W2079567664 @default.
• W2065526578 cites W2082863696 @default.
• W2065526578 cites W2086090222 @default.
• W2065526578 cites W2087386884 @default.
• W2065526578 cites W2089257078 @default.
• W2065526578 cites W2089706884 @default.
• W2065526578 cites W2094685374 @default.
• W2065526578 cites W2096550186 @default.
• W2065526578 cites W2097322240 @default.
• W2065526578 cites W2107328434 @default.
• W2065526578 cites W2112912180 @default.
• W2065526578 cites W2117259571 @default.
• W2065526578 cites W2127763588 @default.
• W2065526578 cites W2129226862 @default.
• W2065526578 cites W2141592118 @default.
• W2065526578 cites W2151616125 @default.
• W2065526578 cites W2165678606 @default.
• W2065526578 cites W2180275997 @default.
• W2065526578 cites W2210366913 @default.
• W2065526578 cites W2333970349 @default.
• W2065526578 cites W2412462667 @default.
• W2065526578 cites W2562414697 @default.
• W2065526578 cites W4246987999 @default.
• W2065526578 cites W4247452643 @default.
• W2065526578 doi "https://doi.org/10.1016/j.oraloncology.2012.06.014" @default.
• W2065526578 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22800881" @default.
• W2065526578 hasPublicationYear "2012" @default.
• W2065526578 type Work @default.
• W2065526578 sameAs 2065526578 @default.
• W2065526578 citedByCount "82" @default.
• W2065526578 countsByYear W20655265782013 @default.
• W2065526578 countsByYear W20655265782014 @default.
• W2065526578 countsByYear W20655265782015 @default.
• W2065526578 countsByYear W20655265782016 @default.
• W2065526578 countsByYear W20655265782017 @default.
• W2065526578 countsByYear W20655265782018 @default.
• W2065526578 countsByYear W20655265782019 @default.
• W2065526578 countsByYear W20655265782020 @default.
• W2065526578 countsByYear W20655265782021 @default.
• W2065526578 countsByYear W20655265782022 @default.
• W2065526578 countsByYear W20655265782023 @default.
• W2065526578 crossrefType "journal-article" @default.
• W2065526578 hasAuthorship W2065526578A5041471791 @default.
• W2065526578 hasAuthorship W2065526578A5060002817 @default.
• W2065526578 hasAuthorship W2065526578A5068859775 @default.
• W2065526578 hasAuthorship W2065526578A5072824146 @default.
• W2065526578 hasAuthorship W2065526578A5080374144 @default.
• W2065526578 hasAuthorship W2065526578A5082631468 @default.
• W2065526578 hasAuthorship W2065526578A5085366844 @default.
• W2065526578 hasConcept C10515644 @default.
• W2065526578 hasConcept C121608353 @default.
• W2065526578 hasConcept C126322002 @default.
• W2065526578 hasConcept C126894567 @default.
• W2065526578 hasConcept C141071460 @default.
• W2065526578 hasConcept C143998085 @default.
• W2065526578 hasConcept C168563851 @default.

• next